Is Henry Schein Stock Underperforming the Nasdaq?
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 01 2025
0mins
Should l Buy HSIC?
Source: NASDAQ.COM
Company Overview: Henry Schein, Inc. is a global healthcare solutions provider with a market cap of $8.5 billion, primarily serving dental and medical professionals, and has experienced a decline in stock value despite reporting a revenue increase in its fourth-quarter results.
Market Performance: The company's shares have underperformed compared to the Nasdaq Composite, with a 16.3% drop from its 52-week high, while analysts maintain a "Moderate Buy" rating with a price target suggesting potential growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HSIC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HSIC
Wall Street analysts forecast HSIC stock price to rise
10 Analyst Rating
5 Buy
3 Hold
2 Sell
Moderate Buy
Current: 76.120
Low
58.00
Averages
76.78
High
90.00
Current: 76.120
Low
58.00
Averages
76.78
High
90.00
About HSIC
Henry Schein, Inc. is a solutions company for health care professionals. Its segments consist of Global Distribution and Value-Added Services, Global Specialty Products and Global Technology. Global Distribution and Value-Added Services include distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other practice services. This segment also markets and sells, under its own corporate brand, a portfolio of consumable merchandise. Global Specialty Products includes manufacturing, marketing and sales of dental implant and biomaterial products; endodontic, orthodontic and orthopedic products and other health care-related products and services. Global Technology includes development and distribution of practice management software, e-services, and other products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Henry Schein One Launches MCP Layer for Dental Practices
- Smart Data Queries: The MCP layer launched by Henry Schein One allows users to query clinical, operational, and financial data in natural language, enhancing data accessibility and enabling team members to quickly obtain information, thereby improving work efficiency.
- Real-Time AI Agents: The platform currently runs several pre-built AI agents, such as real-time insurance verification and automated patient follow-up, which can handle operational tasks without human intervention, expected to significantly reduce labor costs and enhance service quality.
- Custom Workflow Building: The MCP build layer will enable practices and DSOs to configure custom workflows and dashboards, increasing the platform's flexibility and adaptability, helping users optimize operations according to their specific needs.
- Industry Showcase Opportunity: Henry Schein One will showcase these new capabilities at the THRIVELIVE event, where attendees will have the chance to experience them in a live sandbox environment, further promoting technological application and innovation within the industry.
See More
Henry Schein to Release Q1 2026 Financial Results
- Earnings Release Schedule: Henry Schein will announce its Q1 2026 financial results before the market opens on May 5, 2026, demonstrating the company's commitment to transparency and investor communication.
- Live Webcast Conference: A conference call will take place at 8:00 a.m. Eastern Time on the same day, featuring CEO Frederick M. Lowery and CFO Ronald N. South, which enhances investor confidence in the company's future prospects.
- Global Business Overview: Operating in 34 countries, Henry Schein reported sales of $13.2 billion in 2025, with a compound annual growth rate of approximately 11%, reflecting its strong performance in the healthcare solutions market.
- Diverse Products and Services: The company offers over 300 solutions to more than 1 million customers globally, showcasing its extensive influence and market leadership in the healthcare industry.
See More
Henry Schein Board to Reduce Size to 10 Members
- Board Size Adjustment: Henry Schein (HSIC) announced plans to reduce its board from 15 to 10 members, effective after the May 21 stockholder meeting, aiming to enhance decision-making efficiency and optimize corporate governance.
- Executive Retirement and Succession: Chairman Stanley Bergman, who has served for over 30 years, will retire and be named chairman emeritus, reflecting the company's recognition of his long-term contributions while paving the way for new leadership.
- Multiple Directors Not Seeking Reelection: In addition to Bergman, board members Joseph Herring, Robert Hombach, Scott Serota, and Bradley Sheares will not seek reelection, which may influence the company's strategic direction moving forward.
- Leadership Transition Period: Amidst this leadership change, Henry Schein has set a 2026 EPS growth target of 5%-8%, indicating the company's commitment to sustainable growth while maintaining operational stability.
See More
Henry Schein Board Restructuring and Chairman Emeritus Appointment
- Board Size Reduction: Henry Schein announced plans to reduce its Board of Directors from 15 to 10 members following the 2026 Annual Meeting, a move aimed at enhancing decision-making efficiency and optimizing governance structure, which is expected to strengthen the company's competitive position in healthcare solutions.
- Chairman Emeritus Appointment: Stanley M. Bergman will retire after 44 years on the Board and be named Chairman Emeritus, recognizing his significant contributions while ensuring he continues to provide strategic guidance, thereby enhancing leadership stability within the company.
- New Director Nominations: The slate of directors nominated for the 2026 Annual Meeting includes nine members such as Mohamad Ali, with the Board believing this new lineup will foster effective dialogue and debate, thus driving the achievement of the company's strategic objectives.
- Acknowledgment of Retiring Directors: The company expressed gratitude to retiring directors like Joseph L. Herring, emphasizing their expertise and guidance as instrumental to Henry Schein's development, reflecting the company's commitment to valuing its talent and leadership.
See More
Veteran Value Fund Manager Highlights Williams, Henry Schein, and 3 Other Discount Stocks
Market Performance: Wall Street has had a challenging start to the year, with mixed results across different stock categories.
Value vs. Growth Stocks: Investors in value stocks are performing better, as evidenced by the Vanguard Value ETF's 3.3% increase in 2026, contrasting with a 9.5% decline in the Vanguard Growth ETF.
See More
Henry Schein Recognized as One of the 2026 World's Most Ethical Companies for 15th Consecutive Year
- Ethical Recognition: Henry Schein has been named one of the 2026 World's Most Ethical Companies by Ethisphere for the 15th consecutive year, highlighting its excellence in business ethics, compliance, and governance, which reinforces its leadership position in the healthcare solutions industry.
- Corporate Citizenship Commitment: Celebrating 25 years of its global corporate citizenship program, Henry Schein has provided nearly $18 million in cash and products to global charity partners, embodying the company's philosophy of 'doing well by doing good' to enhance access to healthcare.
- Risk Management Enhancement: The company has strengthened its Third-Party Risk Management program by issuing Global Principles & Policy on Third Party Intermediaries, ensuring high standards of ethics and compliance in its relationships with suppliers and partners, thereby mitigating potential business risks.
- Ethical Culture Promotion: Henry Schein has introduced a 'Leading with Integrity: A Toolkit for Ethical Leadership' for managers globally, aiming to enhance employees' ethical awareness and decision-making capabilities, which is crucial for the company's long-term success in ethics and compliance.
See More
Henry Schein One Launches MCP Layer for Dental Practices
- Smart Data Queries: The MCP layer launched by Henry Schein One allows users to query clinical, operational, and financial data in natural language, enhancing data accessibility and enabling team members to quickly obtain information, thereby improving work efficiency.
- Real-Time AI Agents: The platform currently runs several pre-built AI agents, such as real-time insurance verification and automated patient follow-up, which can handle operational tasks without human intervention, expected to significantly reduce labor costs and enhance service quality.
- Custom Workflow Building: The MCP build layer will enable practices and DSOs to configure custom workflows and dashboards, increasing the platform's flexibility and adaptability, helping users optimize operations according to their specific needs.
- Industry Showcase Opportunity: Henry Schein One will showcase these new capabilities at the THRIVELIVE event, where attendees will have the chance to experience them in a live sandbox environment, further promoting technological application and innovation within the industry.
See More
Henry Schein to Release Q1 2026 Financial Results
- Earnings Release Schedule: Henry Schein will announce its Q1 2026 financial results before the market opens on May 5, 2026, demonstrating the company's commitment to transparency and investor communication.
- Live Webcast Conference: A conference call will take place at 8:00 a.m. Eastern Time on the same day, featuring CEO Frederick M. Lowery and CFO Ronald N. South, which enhances investor confidence in the company's future prospects.
- Global Business Overview: Operating in 34 countries, Henry Schein reported sales of $13.2 billion in 2025, with a compound annual growth rate of approximately 11%, reflecting its strong performance in the healthcare solutions market.
- Diverse Products and Services: The company offers over 300 solutions to more than 1 million customers globally, showcasing its extensive influence and market leadership in the healthcare industry.
See More
Henry Schein Board to Reduce Size to 10 Members
- Board Size Adjustment: Henry Schein (HSIC) announced plans to reduce its board from 15 to 10 members, effective after the May 21 stockholder meeting, aiming to enhance decision-making efficiency and optimize corporate governance.
- Executive Retirement and Succession: Chairman Stanley Bergman, who has served for over 30 years, will retire and be named chairman emeritus, reflecting the company's recognition of his long-term contributions while paving the way for new leadership.
- Multiple Directors Not Seeking Reelection: In addition to Bergman, board members Joseph Herring, Robert Hombach, Scott Serota, and Bradley Sheares will not seek reelection, which may influence the company's strategic direction moving forward.
- Leadership Transition Period: Amidst this leadership change, Henry Schein has set a 2026 EPS growth target of 5%-8%, indicating the company's commitment to sustainable growth while maintaining operational stability.
See More
Henry Schein Board Restructuring and Chairman Emeritus Appointment
- Board Size Reduction: Henry Schein announced plans to reduce its Board of Directors from 15 to 10 members following the 2026 Annual Meeting, a move aimed at enhancing decision-making efficiency and optimizing governance structure, which is expected to strengthen the company's competitive position in healthcare solutions.
- Chairman Emeritus Appointment: Stanley M. Bergman will retire after 44 years on the Board and be named Chairman Emeritus, recognizing his significant contributions while ensuring he continues to provide strategic guidance, thereby enhancing leadership stability within the company.
- New Director Nominations: The slate of directors nominated for the 2026 Annual Meeting includes nine members such as Mohamad Ali, with the Board believing this new lineup will foster effective dialogue and debate, thus driving the achievement of the company's strategic objectives.
- Acknowledgment of Retiring Directors: The company expressed gratitude to retiring directors like Joseph L. Herring, emphasizing their expertise and guidance as instrumental to Henry Schein's development, reflecting the company's commitment to valuing its talent and leadership.
See More
Veteran Value Fund Manager Highlights Williams, Henry Schein, and 3 Other Discount Stocks
Market Performance: Wall Street has had a challenging start to the year, with mixed results across different stock categories.
Value vs. Growth Stocks: Investors in value stocks are performing better, as evidenced by the Vanguard Value ETF's 3.3% increase in 2026, contrasting with a 9.5% decline in the Vanguard Growth ETF.
See More
Henry Schein Recognized as One of the 2026 World's Most Ethical Companies for 15th Consecutive Year
- Ethical Recognition: Henry Schein has been named one of the 2026 World's Most Ethical Companies by Ethisphere for the 15th consecutive year, highlighting its excellence in business ethics, compliance, and governance, which reinforces its leadership position in the healthcare solutions industry.
- Corporate Citizenship Commitment: Celebrating 25 years of its global corporate citizenship program, Henry Schein has provided nearly $18 million in cash and products to global charity partners, embodying the company's philosophy of 'doing well by doing good' to enhance access to healthcare.
- Risk Management Enhancement: The company has strengthened its Third-Party Risk Management program by issuing Global Principles & Policy on Third Party Intermediaries, ensuring high standards of ethics and compliance in its relationships with suppliers and partners, thereby mitigating potential business risks.
- Ethical Culture Promotion: Henry Schein has introduced a 'Leading with Integrity: A Toolkit for Ethical Leadership' for managers globally, aiming to enhance employees' ethical awareness and decision-making capabilities, which is crucial for the company's long-term success in ethics and compliance.
See More
